Hyperfine, Inc. (NASDAQ:HYPR) Given Average Rating of "Hold" by Analysts

Key Points

• Analysts have a consensus "Hold" rating on Hyperfine (1 sell, 2 hold, 2 buy) with an average 1‑year price target of $1.45, though Lake Street raised its target to $2.50 (buy) while Weiss Ratings remains a sell.
• Hyperfine remains unprofitable: Q earnings showed EPS of ($0.06) beating estimates by $0.02 on $5.29M revenue, but net margin was -262% and ROE -95%, and analysts expect -0.57 EPS for the fiscal year.
• Insider activity and stock metrics: the CFO and COO each sold 24,188 shares at $1.21 recently, insiders own ~31% of shares, institutions ~15%, and the stock trades near $1.25 with a $122.5M market cap and a 52‑week range of $0.53–$2.22.

Shares of Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $1.45.

HYPR has been the subject of several recent analyst reports. Zacks Research upgraded shares of Hyperfine to a "hold" rating in a research note on Thursday, March 19th. Lake Street Capital raised their target price on shares of Hyperfine from $2.00 to $2.50 and gave the company a "buy" rating in a research note on Thursday, March 19th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Hyperfine in a research note on Thursday, January 22nd.

Hyperfine Stock Up 0.8%

Shares of HYPR stock opened at $1.25 on Wednesday. The firm has a market cap of $122.45 million, a price-to-earnings ratio of -2.84 and a beta of 1.06. The company's 50 day moving average is $1.14 and its 200 day moving average is $1.17. Hyperfine has a 52-week low of $0.53 and a 52-week high of $2.22.

Hyperfine (NASDAQ:HYPR - Get Free Report) last issued its quarterly earnings data on Wednesday, March 18th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.02. The company had revenue of $5.29 million for the quarter, compared to analyst estimates of $5.30 million. Hyperfine had a negative net margin of 262.29% and a negative return on equity of 95.09%. Analysts anticipate that Hyperfine will post -0.57 EPS for the current fiscal year.

Insider Activity at Hyperfine

In other Hyperfine news, CFO Brett Hale sold 24,188 shares of the firm's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the sale, the chief financial officer directly owned 275,812 shares in the company, valued at $333,732.52. This trade represents a 8.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Thomas Teisseyre sold 24,188 shares of the firm's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the completion of the sale, the chief operating officer owned 354,648 shares of the company's stock, valued at approximately $429,124.08. This trade represents a 6.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 30.98% of the stock is owned by company insiders.

Institutional Investors Weigh In On Hyperfine

Several institutional investors have recently bought and sold shares of HYPR. EP Wealth Advisors LLC purchased a new stake in shares of Hyperfine during the fourth quarter valued at $34,000. Sanctuary Advisors LLC grew its holdings in shares of Hyperfine by 130.9% during the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company's stock valued at $39,000 after buying an additional 22,638 shares during the last quarter. Kathmere Capital Management LLC purchased a new stake in shares of Hyperfine during the fourth quarter valued at $51,000. Millennium Management LLC purchased a new stake in shares of Hyperfine during the fourth quarter valued at $55,000. Finally, Cerity Partners LLC purchased a new stake in shares of Hyperfine during the fourth quarter valued at $59,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc NASDAQ: HYPR is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company's flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient's bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.